--- title: "Analysts recommend buying Procter & Gamble on the post-earnings dip" type: "News" locale: "en" url: "https://longbridge.com/en/news/294234989.md" description: "Procter & Gamble (PG) shares fell after missing revenue estimates, yet analysts from RBC Capital Markets and Jefferies recommend buying the stock. They view the dip as an opportunity, citing P&G's strong operational capabilities and resilience against macro volatility. Despite a disappointing quarter, firms maintain positive ratings, expecting market share stabilization and earnings growth in 2026-27 driven by productivity and marketing focus." datetime: "2026-07-29T16:32:21.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/294234989.md) - [en](https://longbridge.com/en/news/294234989.md) - [zh-HK](https://longbridge.com/zh-HK/news/294234989.md) generator: "portal-rs" --- # Analysts recommend buying Procter & Gamble on the post-earnings dip Procter & Gamble (PG) fell in Wednesday trading after missing revenue and organic sales estimates as volume stayed flat during the quarter. Looking ahead, the household products giant expects FY27 core earnings of $6.89 to $7.11 (midpoint $7.00) vs. $7.05 consensus and sees sales growing between 1% and 3%. RBC Capital Markets analyst Nik Modi call... ### Related Stocks - [PG.US](https://longbridge.com/en/quote/PG.US.md) - [RY.US](https://longbridge.com/en/quote/RY.US.md) ## Related News & Research - [A $3.8 Billion Reason Why Procter & Gamble Stock Is in Focus Today](https://longbridge.com/en/news/294987679.md) - [Ancora Advisors LLC Has $32.42 Million Stock Holdings in Procter & Gamble Company (The) $PG](https://longbridge.com/en/news/297392894.md) - [Implantica to host capital markets day after RefluxStop FDA clearance](https://longbridge.com/en/news/298268240.md) - [BUZZ-Street View: Not out of the wash yet but signs are emerging for P&G](https://longbridge.com/en/news/294374815.md) - [NuScale stock vs. Oklo stock: Wall Street says buy one and sell the other](https://longbridge.com/en/news/298452226.md) --- > **Disclaimer: This article is for reference only and does not constitute any investment advice.**